SHL will be holding a webinar through Pharmaceutical Business Review on 17 June at 3pm in London / 10am in New York on 'Prerequisites for a successful drug delivery device development programme.'
SHL Business Development executive director Dr Thomas P Schoenknecht will be presenting the webinar.
The webinar will feature interactive functions such as live polls and a Q&A, giving the audience an opportunity to connect with the presenter in real-time.
Responses from the audience also enable the presenter to address issues that peak the most interest in the group.
Dr Schoenknecht said: "It has always been a great opportunity to be able to present to industry experts, potential and existing customers at different conferences.
"However, not everyone can make the trips in person.
"As a result, I am truly excited to have this opportunity to present via a webinar, where the attendee can join and interact with us from anywhere in the world."
